Aripiprazole extended release injection (Abilify Maintena) See Appendix 3: Metabolic monitoring, for specific recommendations on monitoring
Abilify Abilify Asimtufii Abilify Discmelt Abilify Maintena Abilify MyCite Ritalin (methylphenidate). phentermine. Monitor/Modify Tx.
Arpiprazole/Abilify/Abilify. Maintena/Aristada. Asenapine/Saphris/Secuado As with the adult population, monitoring labs and vital signs are part
Health Canada will continue to monitor side effect information involving Abilify and Abilify Side Effects in Infants and Young Children
aripiprazole was stopped or the dosage was Health Canada will continue to monitor side effect information involving Abilify and Abilify
Tapering off Abilify, A gradual dosage decrease, monitored by a medical professional to mitigate symptoms of withdrawal. ; Abilify Half-life
Arpiprazole/Abilify/Abilify. Maintena/Aristada. Asenapine/Saphris/Secuado As with the adult population, monitoring labs and vital signs are part
Manage NMS with immediate discontinuation of aripiprazole, intensive symptomatic treatment, and monitoring. Discontinue ABILIFY ASIMTUFII or ABILIFY MAINTENA
Health Canada will continue to monitor side effect information involving Abilify and Abilify Maintena, as it does Health Canada will take
Comments